19-41419289-C-T

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4BP6_Very_StrongBP7BA1

The NM_000709.4(BCKDHA):​c.639C>T​(p.Ile213Ile) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00343 in 1,613,130 control chromosomes in the GnomAD database, including 185 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. I213I) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.018 ( 97 hom., cov: 32)
Exomes 𝑓: 0.0019 ( 88 hom. )

Consequence

BCKDHA
NM_000709.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 2.02

Publications

1 publications found
Variant links:
Genes affected
BCKDHA (HGNC:986): (branched chain keto acid dehydrogenase E1 subunit alpha) The branched-chain alpha-keto acid (BCAA) dehydrogenase (BCKD) complex is an innter mitochondrial enzyme complex that catalyzes the second major step in the catabolism of the branched-chain amino acids leucine, isoleucine, and valine. The BCKD complex consists of three catalytic components: a heterotetrameric (alpha2-beta2) branched-chain alpha-keto acid decarboxylase (E1), a dihydrolipoyl transacylase (E2), and a dihydrolipoamide dehydrogenase (E3). This gene encodes the alpha subunit of the decarboxylase (E1) component. Mutations in this gene result in maple syrup urine disease, type IA. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Sep 2009]
BCKDHA Gene-Disease associations (from GenCC):
  • maple syrup urine disease
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • maple syrup urine disease type 1A
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P, ClinGen, Myriad Women’s Health
  • classic maple syrup urine disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • intermediate maple syrup urine disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • intermittent maple syrup urine disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • thiamine-responsive maple syrup urine disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

BP4
Computational evidence support a benign effect (REVEL=0.275).
BP6
Variant 19-41419289-C-T is Benign according to our data. Variant chr19-41419289-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 93366.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=2.02 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0602 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000709.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BCKDHA
NM_000709.4
MANE Select
c.639C>Tp.Ile213Ile
synonymous
Exon 5 of 9NP_000700.1P12694-1
BCKDHA
NM_001164783.2
c.639C>Tp.Ile213Ile
synonymous
Exon 5 of 9NP_001158255.1Q59EI3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BCKDHA
ENST00000269980.7
TSL:1 MANE Select
c.639C>Tp.Ile213Ile
synonymous
Exon 5 of 9ENSP00000269980.2P12694-1
ENSG00000255730
ENST00000540732.3
TSL:2
c.741C>Tp.Ile247Ile
synonymous
Exon 6 of 10ENSP00000443246.1F5H5P2
BCKDHA
ENST00000919033.1
c.639C>Tp.Ile213Ile
synonymous
Exon 5 of 10ENSP00000589092.1

Frequencies

GnomAD3 genomes
AF:
0.0179
AC:
2719
AN:
152188
Hom.:
94
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0622
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00641
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.000191
Gnomad OTH
AF:
0.0124
GnomAD2 exomes
AF:
0.00461
AC:
1148
AN:
248758
AF XY:
0.00341
show subpopulations
Gnomad AFR exome
AF:
0.0635
Gnomad AMR exome
AF:
0.00286
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000169
Gnomad OTH exome
AF:
0.00230
GnomAD4 exome
AF:
0.00192
AC:
2808
AN:
1460824
Hom.:
88
Cov.:
31
AF XY:
0.00172
AC XY:
1249
AN XY:
726608
show subpopulations
African (AFR)
AF:
0.0687
AC:
2297
AN:
33440
American (AMR)
AF:
0.00312
AC:
139
AN:
44574
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26104
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39666
South Asian (SAS)
AF:
0.000232
AC:
20
AN:
86062
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53354
Middle Eastern (MID)
AF:
0.00486
AC:
28
AN:
5764
European-Non Finnish (NFE)
AF:
0.0000774
AC:
86
AN:
1111494
Other (OTH)
AF:
0.00394
AC:
238
AN:
60366
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
160
320
479
639
799
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
76
152
228
304
380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0179
AC:
2725
AN:
152306
Hom.:
97
Cov.:
32
AF XY:
0.0168
AC XY:
1250
AN XY:
74464
show subpopulations
African (AFR)
AF:
0.0622
AC:
2586
AN:
41562
American (AMR)
AF:
0.00640
AC:
98
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.000208
AC:
1
AN:
4818
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000191
AC:
13
AN:
68028
Other (OTH)
AF:
0.0123
AC:
26
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
131
262
393
524
655
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0103
Hom.:
19
Bravo
AF:
0.0206
Asia WGS
AF:
0.00549
AC:
19
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
Maple syrup urine disease (2)
-
-
2
Maple syrup urine disease type 1A (2)
-
-
2
not specified (2)
-
-
1
BCKDHA-related disorder (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.26
CADD
Benign
10
DANN
Benign
0.84
PhyloP100
2.0
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10404506; hg19: chr19-41925194; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.